| Male | Female | Total | Mean ± SD | Range | |
Patient No. | 20 (37.7%) | 33 (62.3%) | 53 (100%) |
|
| |
Age(years) | 35.50 ± 7.50 | 32.79 ± 8.02 |
| 33.81 ± 7.87 | (18 - 50) | |
Age of onset (years) | 32.17 ± 7.07 | 29.76 ± 7.26 |
| 30.65 ± 7.22 | (21 - 48) | |
Disease duration (months) | 40.00 ± 27.10 | 36.39 ± 20.89 |
| 37.75 ± 23.24 | (3 - 120) | |
EDSS | 2.50 ± 1.85 | 1.03 ± 1.63 |
| 1.58 ± 1.84 | (0 - 6) | |
MS Types | RR | 10 (18.9%) | 14 (26.4%) | 24 (45.3%) |
|
|
PP | 5 (9.4%) | 8 (15.1%) | 13 (24.5%) |
|
| |
SP | 3 (5.7%) | 6 (11.3%) | 9 (17.0%) |
|
| |
CIS | 2 (3.8%) | 5 (9.4%) | 7 (13.2%) |
|
| |
Cognitive Impairment | No | 4 (7.5%) | 12 (22.6%) | 16 (30.2%) |
|
|
Mild | 5 (9.4%) | 16 (30.2%) | 21 (39.6%) |
|
| |
Moderate | 8 (15.1%) | 3 (5.7%) | 11 (20.8%) |
|
| |
Severe | 3 (5.7%) | 2 (3.8%) | 5 (9.4%) |
|
|